Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

Recognizing that the pandemic has exacerbated health inequities among the nation’s most vulnerable groups, UCLA Health engaged with regional stakeholders spanning different industry sectors to ...

Citing changing consumer needs, CVS Health plans to close 900 of its pharmacies over the next three years. At the same time, it wants to revamp a growing number of them to focus on health services ...

Cadence, a provider of remote patient monitoring and virtual care services, has come out of stealth mode(Opens in a new window) with $41 million in funding from ...

As Congress deliberates what the future of Medicaid funding will look like, healthcare executives are worried. House Republicans proposed Medicaid cuts last month that would have sweeping and ...